ABUS: the cash flow

MyFinsight

For the year ending 2025-12-31, ABUS had -$18,322K decrease in cash & cash equivalents over the period. -$39,637K in free cash flow.

Cash Flow	2025-12-31
Net loss	-33,501
Depreciation and amortization	363
Restructuring, settlement and impairment provisions	2,811
Gain on sale of property and equipment	674
Stock-based compensation expense	6,953
Change in fair value of contingent consideration	-1,830
Non-cash royalty revenue	1,482
Non-cash interest expense	95
Net accretion of investments in marketable securities	2,349
Accounts receivable	-1,375
Prepaid expenses and other assets	-1,698
Accounts payable and accrued liabilities	-2,105
Change in deferred license revenue	-10,434
Other liabilities	-557
Net cash used in operating activities	-39,637
Purchase of investments in marketable securities	140,061
Disposition of investments in marketable securities	155,277
Proceeds from sale of property and equipment	364
Acquisition of property and equipment	0
Net cash provided by investing activities	15,580
Issuance of common shares pursuant to the open market sale agreement	0
Issuance of common shares pursuant to exercise of stock options	5,540
Issuance of common shares pursuant to espp	181
Net cash provided by financing activities	5,721
Effect of foreign exchange rate changes on cash and cash equivalents	14
(decrease) / increase in cash and cash equivalents	-18,322
Cash and cash equivalents, beginning of period	36,330
Cash and cash equivalents, end of period	18,008

Unit: Thousand (K) dollars (except for numbers of shares and EPS).